Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Clinical Trial Progress at Annual General Meeting

Living Cell Technologies Updates Shareholders on Clinical Trial Progress at Annual General Meeting

November 27, 2007 – Melbourne, Australia and Auckland, New Zealand Living Cell Technologies Limited (ASX:LCT; OTC: LVCLY.PK) today updated shareholders at its Annual General Meeting on the Company’s Russian clinical trial, the status of its New Zealand clinical trial and commercialisation plans.

Professor Bob Elliot, Medical Director of LCT, announced that a third patient in the Russian Clinical Trial was implanted with the first dose of DiabeCell® and is due for a second dose in six months. DiabeCell® is administered to patients without the need for immunosuppressant drugs.

The first patient implanted with DiabeCell® in June 2007 has maintained a 40% reduction in his insulin requirement at five months followup. This patient is due for a second dose of DiabeCell® in December.

The second patient having received only the first dose of DiabeCell® in September 2007 remains insulin independent at two months follow up.

Professor Elliott stated, ‘ We are very encouraged by the positive preliminary data from the first two patients in the Russian trial and look forward to providing more detailed updates on all three patients by the end of first quarter 2008.'

Dr Paul Tan, CEO of Living Cell Technologies said, ‘ LCT’s most important milestone for 2008 is to complete the Phase I/IIa clinical trial in Russia. Additionally we look forward to receiving endorsement of our ethics and regulatory approval by the new Health Minister which will enable the New Zealand clinical trial to commence.’

The Company emphasised that while the results to date are preliminary and need to be seen in the context of full clinical trial data, a continuation of the better than expected clinical response is a positive step in the Company’s path towards commercialisation. Accordingly other major milestones over the next 12 months include upscaling the production capabilities and expansion of LCT’s unique pig herd.

ENDS

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 


FMA: Files Civil Proceedings Against Kiwibank For False Or Misleading Representations Over Fee Waivers

The Financial Markets Authority (FMA) - Te Mana Tātai Hokohoko has filed High Court civil proceedings against Kiwibank for making false and/or misleading representations, under the fair dealing provisions of the Financial Markets Conduct Act (FMC Act)... More>>

ALSO:


What Lies Beneath: Is The Housing Market Turning?
Rising interest rates, combined with further tightening of credit availability appear to be dampening the enthusiasm of investors and first home buyers. While house values continue to rise, what lies beneath QV's latest figures is growing evidence that price pressure has shifted... More>>



R&NTU: KiwiRail strike notices withdrawn following new offer

Strike notices on KiwiRail have been withdrawn. Rail and Maritime Transport Union General Secretary Wayne Butson says following negotiations between the RMTU and KiwiRail, a new offer from KiwiRail will be taken back to union members for ratification... More>>


Reserve Bank: Deputy Governor Reflects On Time At RBNZ
Central bankers must continue to look forward to guard against the unpredictable, Deputy Governor Geoff Bascand says in a speech published today. Mr Bascand joined the Reserve Bank of New Zealand – Te Pūtea Matua in 2013 during the aftermath of the Global Financial Crisis... More>>


Xero: Data Reveals ICT Expenditure Key To Small Business Sales Growth
Xero, the global small business platform, today released a new report which shows New Zealand small business ICT expenditure has increased 25 percent compared to pre-pandemic levels - more than the UK (20%) and Australia... More>>


Fonterra: Lifts Forecast Farmgate Milk Price Range And Revises Earnings Guidance At First Quarter Update

Fonterra Co-operative Group today lifted its 2021/22 forecast Farmgate Milk Price range, reported a solid start to the 2022 financial year and revised its earnings guidance... More>>


Canterbury Museum: New Research - Bald Haast's Eagle Feasted On Moa Guts

New Zealand’s extinct Haast’s Eagle (Hieraaetus moorei), the largest known eagle, gulped down viscera like a vulture and may even have been bald, new research suggests... More>>